Please login to the form below

Not currently logged in
Email:
Password:

Aerocrine

This page shows the latest Aerocrine news and features for those working in and with pharma, biotech and healthcare.

Circassia slumps as cat allergy vaccine fails late-stage trial

Circassia slumps as cat allergy vaccine fails late-stage trial

drugs and novel combinations gained through its acquisitions of Aerocrine and Prosonix last year.

Latest news

  • Allergy specialist Circassia buys asthma firms Allergy specialist Circassia buys asthma firms

    Circassia will pay £139m ($219m) for Aerocrine and up to £100m for Prosonix. ... Circassia will use Aerocrine's established commercial operation to help with the launch of its new cat allergy treatment Cat-SPIRE.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics